Toboroz
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
NCT07359820· 2. fázis· Elevar Therapeutics· Forrás
Contact: Clinical Trial and Research Office
Toboroz
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
NCT07549412· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás
Contact: Communication Center
Toboroz
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445· 3. fázis· Revolution Medicines, Inc.· Forrás
Contact: SCRI Referrals Team
Toboroz
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
NCT07063745· 2/3. fázis· Bristol-Myers Squibb· Forrás
Contact: Anja Williams, Site 0228
Toboroz
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
NCT07213674· 3. fázis· Amgen· Forrás
Fut, nem toboroz
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT07076121· 2/3. fázis· Bristol-Myers Squibb· Forrás
Toboroz
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
NCT07144280· 3. fázis· Pfizer· Forrás
Toboroz
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
NCT06855771· 2. fázis· Bristol-Myers Squibb· Forrás
Contact: Elisa Fontana, Site 0008
Toboroz
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06982521· 3. fázis· Relay Therapeutics, Inc.· Forrás
Contact: Relay Therapeutics, Inc
Toboroz
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
NCT07094113· 1. fázis· Amgen· Forrás
Toboroz
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
NCT06644781· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
NCT06731478· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma
NCT06784648· 1/2. fázis· BioInvent International AB· Forrás
Fut, nem toboroz
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
NCT06691984· 3. fázis· Amgen· Forrás
Toboroz
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
NCT06561386· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Anja Williams, Site 0464
Fut, nem toboroz
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
NCT06506955· 2/3. fázis· Taiho Oncology, Inc.· Forrás
Toboroz
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
NCT06252649· 3. fázis· Amgen· Forrás
Toboroz
A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
NCT06372717· 1. fázis· Apollo Therapeutics Ltd· Forrás
Contact: Sarah Cannon Research Institute
Fut, nem toboroz
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
NCT06360354· 1. fázis· Amgen· Forrás
Fut, nem toboroz
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
NCT06012435· 3. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás
Fut, nem toboroz
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
NCT06105632· 2. fázis· Pfizer· Forrás
Toboroz
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
NCT06131840· 1. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás
Toboroz
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
NCT05727904· 3. fázis· Iovance Biotherapeutics, Inc.· Forrás
Contact: Iovance Biotherapeutics Study Team
Toboroz
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
NCT05573126· 1/2. fázis· Ellipses Pharma· Forrás
Contact: Clinical Trials Team
Toboroz
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT05549297· 3. fázis· Immunocore Ltd· Forrás
Toboroz
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022· 1. fázis· Nurix Therapeutics, Inc.· Forrás
Fut, nem toboroz
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
NCT05094336· 1/2. fázis· Amgen· Forrás
Fut, nem toboroz
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016· 2. fázis· Amgen· Forrás
Toboroz
First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
NCT05104515· 1. fázis· Oxford Vacmedix UK Ltd.· Forrás
Contact: Anja Williams
Fut, nem toboroz
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT04691804· 3. fázis· Jiangsu HengRui Medicine Co., Ltd.· Forrás
Toboroz
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068· 1/2. fázis· Artios Pharma Ltd· Forrás
Contact: Sarah Cannon Development Innovations
Toboroz
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
NCT04752826· 1/2. fázis· BioInvent International AB· Forrás
Contact: Anja Williams (principal investigator)
Fut, nem toboroz
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
NCT04579380· 2. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás
Toboroz
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750· 1/2. fázis· PMV Pharmaceuticals, Inc· Forrás
Contact: Elisa Fontana, MD, PhD
Toboroz
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
NCT04557449· 2. fázis· Pfizer· Forrás
Fut, nem toboroz
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362· 1/2. fázis· BicycleTx Limited· Forrás
Fut, nem toboroz
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
NCT04478279· 1/2. fázis· Sapience Therapeutics· Forrás
Fut, nem toboroz
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
NCT04185883· 1. fázis· Amgen· Forrás
Fut, nem toboroz
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
NCT04180371· 1/2. fázis· BicycleTx Limited· Forrás
Toboroz
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
NCT04068597· 1/2. fázis· CellCentric Ltd.· Forrás
Contact: Richard Dillon
Fut, nem toboroz
Avelumab Program Rollover Study
NCT03815643· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás
Fut, nem toboroz
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
NCT03336333· 3. fázis· BeiGene· Forrás